Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series
- 2 September 2020
- journal article
- letter
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 61 (14), 3515-3518
- https://doi.org/10.1080/10428194.2020.1815018
Abstract
(2020). Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series. Leukemia & Lymphoma. Ahead of Print.This publication has 15 references indexed in Scilit:
- Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapyBlood, 2016
- Detection of Lymphoid and Myeloid Lineages in Infantile B-Cell Acute Lymphoblastic Leukemia With Mixed-Lineage Leukemia Rearrangement by Use of Flow Cytometry and Cytogenetic AnalysisClinical Lymphoma Myeloma and Leukemia, 2014
- Lineage Switching in Acute Leukemias: A Consequence of Stem Cell Plasticity?Bone Marrow Research, 2012
- Lineage switch in childhood acute leukemia: An unusual event with poor outcomeAmerican Journal of Hematology, 2012
- Early lineage switch in an infant acute lymphoblastic leukemiaInternational Journal of Hematology, 2009
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesBlood, 2009
- Chromosomal Rearrangements Leading to MLL Gene Fusions: Clinical and Biological AspectsCancer Research, 2008
- A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trialThe Lancet, 2007
- Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: Proposal for an easy strategyMedical and Pediatric Oncology, 2001
- Lineage switch in acute leukemiaBlood, 1984